188 related articles for article (PubMed ID: 27992685)
1. Biologic Therapy for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Comment on the Article by Jachiet et al.
Novikov P; Moiseev S
Arthritis Rheumatol; 2017 Apr; 69(4):870-871. PubMed ID: 27992685
[No Abstract] [Full Text] [Related]
2. The Role of Omalizumab in Patients With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Comment on the Article by Jachiet et al.
Detoraki A; Varricchi G; Genovese A; Marone G; Spadaro G
Arthritis Rheumatol; 2017 Apr; 69(4):868-870. PubMed ID: 27992689
[No Abstract] [Full Text] [Related]
3. Development of eosinophilic granulomatosis with poliangiitis (Churg-Strauss syndrome) and brain tumor in a patient after more than 7 years of omalizumab use: A case report.
Borekci S; Aydin O; Hatemi G; Gemicioglu B
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):134-7. PubMed ID: 25816417
[TBL] [Abstract][Full Text] [Related]
4. Does the revised definition of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) indicate the need for a new treatment? Comment on the article by Puéchal et al.
Smitienko I; Novikov P; Moiseev S
Arthritis Rheumatol; 2018 Jan; 70(1):149-151. PubMed ID: 28950437
[No Abstract] [Full Text] [Related]
5. A case of omalizumab-associated eosinophilic granulomatosis with polyangiitis.
Yamaki Y; Hayashi D; Honda K; Imai H; Takada H
Pediatr Int; 2021 Sep; 63(9):1119-1121. PubMed ID: 34170601
[No Abstract] [Full Text] [Related]
6. Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review.
Raffray L; Guillevin L
Drugs; 2018 Jun; 78(8):809-821. PubMed ID: 29766394
[TBL] [Abstract][Full Text] [Related]
7. Omalizumab-associated eosinophilic granulomatosis with polyangiitis: cause or coincidence?
Carson LN; Pradhan A; Subramanian D
BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34326107
[TBL] [Abstract][Full Text] [Related]
8. Omalizumab: a novel steroid sparing agent in eosinophilic granulomatosis with polyangiitis?
Latorre M; Baldini C; Seccia V; Notarstefano C; Della Rossa A; Tani C; Talarico R; Mosca M; Paggiaro PL
Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S91-2. PubMed ID: 23075542
[No Abstract] [Full Text] [Related]
9. Biologics for Eosinophilic Granulomatosis With Polyangiitis-One Size Does Not Fit All: Comment on the Article by Canzian et al.
Caminati M; Giollo A; Senna G; Lunardi C
Arthritis Rheumatol; 2021 Jul; 73(7):1346-1347. PubMed ID: 33605091
[No Abstract] [Full Text] [Related]
10. Therapeutic immunomodulation in eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
Puéchal X
Joint Bone Spine; 2016 Jan; 83(1):7-10. PubMed ID: 26639221
[No Abstract] [Full Text] [Related]
11. [Acute myocardial infarction as Eosinophilic granulomatosis with polyangiitis (formerly Churg Strauss syndrome) initial presentation].
Sulaiman W; Seung OP; Noor SM
Rev Bras Reumatol; 2014; 54(5):393-6. PubMed ID: 25627304
[TBL] [Abstract][Full Text] [Related]
12. Response to: 'Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) induced by immune checkpoint inhibitors' by Delyon
Kostine M; Schaeverbeke T;
Ann Rheum Dis; 2019 Aug; 78(8):e83. PubMed ID: 30054370
[No Abstract] [Full Text] [Related]
13. Sequential rituximab and omalizumab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
Aguirre-Valencia D; Posso-Osorio I; Bravo JC; Bonilla-Abadía F; Tobón GJ; Cañas CA
Clin Rheumatol; 2017 Sep; 36(9):2159-2162. PubMed ID: 28762062
[TBL] [Abstract][Full Text] [Related]
14. [Dilated cardiomyopathy in a patient with Eosinophilic Granulomatosis with Polyangiitis (Churg Strauss)].
Lozita J; Vicentín JM; Melgarejo Otarola MF; Paolasso JA; Colque RMA; Sarmiento PE
Rev Fac Cien Med Univ Nac Cordoba; 2022 Jun; 79(2):193-196. PubMed ID: 35700466
[TBL] [Abstract][Full Text] [Related]
15. [Neurological disorders in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)].
Gilyarov MY; Belikova LP; Shchukin IA; Fidler MS; Avakyan GG; Shustrova GE; Martynov MY; Svet AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):93-102. PubMed ID: 28635862
[TBL] [Abstract][Full Text] [Related]
16. Omalizumab-associated eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
Nazir S; Tachamo N; Fareedy SB; Khan MS; Lohani S
Ann Allergy Asthma Immunol; 2017 Mar; 118(3):372-374.e1. PubMed ID: 28094120
[No Abstract] [Full Text] [Related]
17. [Acute cerebral sinus-thrombosis due to polyangiitis overlap syndrome with granulomatosis with polyangiitis (Wegener's granulomatosis) and eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)].
Shuleshova NV; Skoromets AA; Matskevich OR; Kiryanov YM
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(12. Vyp. 2):30-35. PubMed ID: 28300800
[TBL] [Abstract][Full Text] [Related]
18. Eosinophilic granulomatosis with polyangiitis with heterozygous familial hypercholesterolemia: A tricky therapeutic approach with omalizumab and evolocumab.
Sbrana F; Dal Pino B; Ferro F; Corciulo C; Puxeddu I; Baldini C
Nutr Metab Cardiovasc Dis; 2023 Feb; 33(2):461-464. PubMed ID: 36642612
[No Abstract] [Full Text] [Related]
19. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) induced by immune checkpoint inhibitors.
Roger A; Groh M; Lorillon G; Le Pendu C; Maillet J; Arangalage D; Tazi A; Lebbe C; Baroudjian B; Delyon J;
Ann Rheum Dis; 2019 Aug; 78(8):e82. PubMed ID: 29936437
[No Abstract] [Full Text] [Related]
20. Eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): where are we now?
Groh M; Pagnoux C; Guillevin L
Eur Respir J; 2015 Nov; 46(5):1255-8. PubMed ID: 26521277
[No Abstract] [Full Text] [Related]
[Next] [New Search]
